My blog has moved!

You should be automatically redirected in 6 seconds. If not, visit the page Planner's Thoughts at
http://StrattonPlanning.com
and update your bookmarks.

Wednesday, July 19, 2006

Upcoming Malpractice Avoidance Seminar

Photobucket - Video and Image Hosting

Next Wednesday on July 26, 2006, I will be presenting a seminar on malpractice avoidance by financial planners, entitled Judo for Financial Planners: Strategies for Avoiding Malpractice Claims, at the San Gabriel Valley Chapter of the Financial Planning Association.

1 comment:

Danny Haszard said...

I took zyprexa which was ineffective for my condition and gave me diabetes.

Zyprexa, which is used for the treatment of psychiatric disorders, such as schizophrenia and bipolar disorder, accounted for 32% of Eli Lilly's $14.6 billion revenue last year.

Zyprexa is the product name for Olanzapine,it is Lilly's top selling drug.It was approved by the FDA in 1996 ,an 'atypical' antipsychotic a newer class of drugs without the motor side effects of the older Thorazine.Zyprexa has been linked to causing diabetes and pancreatitis.

Did you know that Lilly made nearly $3 billion last year on diabetic meds, Actos,Humulin and Byetta?

Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

I was prescribed Zyprexa from 1996 until 2000.
In early 2000 i was shocked to have an A1C test result of 13.9 (normal is 4-6) I have no history of diabetes in my family.
----
Daniel Haszard http://www.zyprexa-victims.com